On Friday afternoon, as results from the Primary Leaving Examination (PLE) began circulating across Uganda, the familiar ...
“Extreme risk protection orders save lives. Red flag laws prevent harm,” Sen. Julie Gonzales, a Denver Democrat who supported the bill, said. “These policies, and this bill that we are debating here ...
Hochul, who faced a closer-than-expected race in 2022, is leading polls and securing key endorsements in her reelection bid.
“It is not one person’s problem, we were all concerned to see that all the pupils had been marked xx and upon a thorough ...
In the governor’s race, Steyer pumped a total of $28.8 million into his campaign through the end of last year, according to ...
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in ...
1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...
Walmart is a great place to find great deals on inexpensive tools and technology, but not everything there is a great find. Here's what to avoid.
Union Budget 2026 prioritizes sustainable employment. The focus is on skilling, services, and sector-led ecosystems.
Student scores in math achievement have dropped under inquiry-based instruction. But some school boards are returning to an ...
Zacks Investment Research on MSN
Sanofi's venglustat meets primary endpoints in Gaucher disease study
Sanofi SNY announced that a late-stage study, evaluating venglustat, an investigational oral glucosylceramide synthase inhibitor (GCSi), in patients aged 12 years and older with type 3 Gaucher disease ...
Back in the day’ butts heads with ‘medicine today.’ A candid look at why physicians may never have the authority, respect, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results